Controlled release of drugs: polymers and aggregate systems
Saved in:
| Format: | Book |
|---|---|
| Language: | English |
| Published: |
New York, NY u.a.
VCH
1989
|
| Subjects: | |
| Online Access: | Inhaltsverzeichnis |
| Physical Description: | XI, 315 S. Ill., graph. Darst. |
| ISBN: | 0895733218 3527267972 |
Staff View
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV001849953 | ||
| 003 | DE-604 | ||
| 005 | 19930602 | ||
| 007 | t | ||
| 008 | 890612s1989 ad|| |||| 00||| eng d | ||
| 020 | |a 0895733218 |9 0-89573-321-8 | ||
| 020 | |a 3527267972 |9 3-527-26797-2 | ||
| 035 | |a (OCoLC)18106215 | ||
| 035 | |a (DE-599)BVBBV001849953 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 |a DE-355 |a DE-210 | ||
| 050 | 0 | |a QV785 | |
| 082 | 0 | |a 615.191 |2 19 | |
| 084 | |a VX 8550 |0 (DE-625)147830:253 |2 rvk | ||
| 245 | 1 | 0 | |a Controlled release of drugs |b polymers and aggregate systems |c ed. by Morton Rosoff |
| 264 | 1 | |a New York, NY u.a. |b VCH |c 1989 | |
| 300 | |a XI, 315 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 650 | 4 | |a Controlled release technology | |
| 650 | 4 | |a Delayed-Action Preparations | |
| 650 | 4 | |a Dosage Forms | |
| 650 | 4 | |a Drug carriers (Pharmacy) | |
| 650 | 4 | |a Drugs |x Controlled release | |
| 650 | 4 | |a Polymers |x therapeutic use | |
| 650 | 0 | 7 | |a Wirkstofffreisetzung |0 (DE-588)4190018-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Kontrollierte Wirkstofffreisetzung |0 (DE-588)4165181-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittel |0 (DE-588)4003115-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneiform |0 (DE-588)4068874-4 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 689 | 0 | 0 | |a Arzneiform |0 (DE-588)4068874-4 |D s |
| 689 | 0 | 1 | |a Wirkstofffreisetzung |0 (DE-588)4190018-2 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Kontrollierte Wirkstofffreisetzung |0 (DE-588)4165181-9 |D s |
| 689 | 1 | 1 | |a Arzneimittel |0 (DE-588)4003115-9 |D s |
| 689 | 1 | |5 DE-604 | |
| 700 | 1 | |a Rosoff, Morton |e Sonstige |4 oth | |
| 856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=001225892&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-001225892 | ||
Record in the Search Index
| _version_ | 1804116316590702592 |
|---|---|
| adam_text | CONTROUED RELEASE OF DRUGS: POLYMERS AND AGGREGATE SYSTEMS EDITED BY
NORTON ROSOFF VCH PUBLISHERS CONTENTS CHAPTER 1 MODEUNG OF DRUG RELEASE
FROM POROUES POLYMERS 1 RONALD A SIEGEL I. INTRODUCTION 1 II. DRUG FLOW
THROUGH AND FROM MACROPOROUS HYDROPHOBIE ** POLYMERS 2 III. EFFECT OF
PORE STRUCTURE ON DIFFUSION RATES 13 IV. MICROPOROUS SYSTEMS 40 V.
MACROPOROUS SYSTEMS WHERE THE POLYMER IS HYDROPHILIC 46 VI. CONCLUSION
49 CHAPTER 2 BIODEGRADABLE POLYMERS FOR CONTROLLED RELEASE OF DRUEGS 53
ROBERT J. LINHARDT I. INTRODUCTION 53 II. MODES OF POLYMER EROSION AND
DRUG RELEASE 57 III. BIODEGRADABLE POLYMERS 69 IV. FORMULATION,
ADMINISTRATION, AND EVALUATION 73 V. SURVEY OF BIODEGRADABLE POLYMERS IN
DRUG DELIVERY 77 CHAPTER 3 DISPERSED SYSTEMS FOR PARENTERAL
ADMINISTRATION 97 CURT THIES I. TYPES OF TARGETING 97 II. TYPES OF
CARRIER SYSTEMS 98 III. REQUIREMENTS OF PARENTERAL DRUG DELIVERY SYSTEMS
99 IV. MATERIALS FOR FABRICATING PARTICULATE DRUG CAMERS 100 V.
FORMATION OF DISPERSED SYSTEMS 105 VI. LIPOSOMES 113 VII. NIOSOMES:
NONIONIC SURFACTANT VESICLES 114 VIII. LOADED ERYTHROCYTES 115 IX.
PARENTERAL EMULSIONS 116 X. NANOPARTICLES 117 XI. SUMMARY COMMENTS 119 X
CONTENTS CHAPTER 4 LIQUID CRYSTALS AND THEIR APPLICATIONS IN DRUEG
DELIVERY 125 PRAUEEN TYLE I. INTRODUCTION 125 II. CLASSIFICATION OF
LIQUID CRYSTALS 126 III. EMULSIFIER*EMULSIFIER ASSOCIATION 133 IV. ROLE
IN STABILITY OF FORMULATIONS 144 V. APPLICATIONS IN CONTROUED DRUG
DELIVERY 156 CHAPTER 5 MULTIPLE W/O/W EMCILSIONS AS DRUEG VEHICLES 163 A
T. FLORENCE, J. A. OMOTOSHO, AND T. L WHATELEY I. INTRODUCTION 163 II.
COMPOSITION OF THE MULTIPLE EMULSION AND STABILITY: INFLUENCE OF THE
NATURE OF OIL PHASE 165 III. METHODS AVAILABLE FOR STABILIZING W/O/W
MULTIPLE EMULSIONS 166 IV. MECHANISMS OF TRANSPORT OF SOLUTES 172 V. IN
VIVO STUDIES 776 CHAPTER 6 MICROEMUELSIONS: AN EVOLVING TECHNOLOGY FOR
PHARMACECITICAL APPLICATIONS 185 ROGER LEUNG AND DINESH O. SHAH I.
INTRODUCTION 185 II. STRUCTURE OF MICROEMULSIONS 792 III.
SOLUBILIZATION AND FORMULATION OF MICROEMULSIONS 200 IV. TRANSPORT
PROPERTIES AND PHARMACEUTICAL APPLICATIONS OF MICROEMULSIONS 209 CHAPTER
7 COMMERCIAL APPROACHES TO THE DELIVERY OF MACROMOLECUELAR DRUEGS WITH
LIPOSOMES 217 ALAN L. WEINER, JOHN B. CANNON, AND PRAUEEN TYLE I.
INTRODUCTION 277 II. MATERIALS FOR PREPARATION 279 III. PROCESSES FOR
LIPOSOME MANUFACTURE 222 IV. SUSTAINED DRUG DELIVERY FROM LIPOSOMES 236
V. SPECIFIC APPLICATIONS OF LIPOSOMES FOR DELIVERY OF MACROMOLECULES 243
CONTENTS XI CHAPTER 8 SOLUBILIZATION AND STRUECTCIRAL PROPERTIE5 OF
NUECLEIC ACIDS IN REVERSE MICELLES 255 BATTISTEL EZIO, IMRE ERGIN VELIN,
AND LUISI PIER LUIGI I. INTRODUCTION 256 II. EXPERIMENTAL PROCEDURES 257
III. RESULTS 258 IV. DISCUSSION 272 CHAPTER 9 TRANSDERMAL DRUG DELIVERY
SYSTEMS 277 RICHARD BAKER AND FRANK KOCHINKE I. INTRODUCTION 277 II.
DEVICE DESIGN 278 III. SKIN OR DEVICE RATE CONTROL 283 IV. SKIN DEPOT
EFFECTS 287 V. SKIN PERMEABILITY: PUBLISHED DATA RELIABILITY 297 VI.
SKIN PERMEABILITY MEASUREMENTS 293 VII. PREDICTION OF SKIN PERMEABILITY
298 VIII. SKIN PERMEATION ENHANCEMENT 299 IX. CONCLUSIONS 303 INDEX 307
|
| any_adam_object | 1 |
| building | Verbundindex |
| bvnumber | BV001849953 |
| callnumber-first | Q - Science |
| callnumber-label | QV785 |
| callnumber-raw | QV785 |
| callnumber-search | QV785 |
| callnumber-sort | QV 3785 |
| classification_rvk | VX 8550 |
| ctrlnum | (OCoLC)18106215 (DE-599)BVBBV001849953 |
| dewey-full | 615.191 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615.191 |
| dewey-search | 615.191 |
| dewey-sort | 3615.191 |
| dewey-tens | 610 - Medicine and health |
| discipline | Chemie / Pharmazie Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02005nam a2200517 c 4500</leader><controlfield tag="001">BV001849953</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">19930602 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">890612s1989 ad|| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0895733218</subfield><subfield code="9">0-89573-321-8</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3527267972</subfield><subfield code="9">3-527-26797-2</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)18106215</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV001849953</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-210</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">QV785</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.191</subfield><subfield code="2">19</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VX 8550</subfield><subfield code="0">(DE-625)147830:253</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Controlled release of drugs</subfield><subfield code="b">polymers and aggregate systems</subfield><subfield code="c">ed. by Morton Rosoff</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York, NY u.a.</subfield><subfield code="b">VCH</subfield><subfield code="c">1989</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XI, 315 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Controlled release technology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Delayed-Action Preparations</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Dosage Forms</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug carriers (Pharmacy)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Controlled release</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Polymers</subfield><subfield code="x">therapeutic use</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Wirkstofffreisetzung</subfield><subfield code="0">(DE-588)4190018-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Kontrollierte Wirkstofffreisetzung</subfield><subfield code="0">(DE-588)4165181-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneiform</subfield><subfield code="0">(DE-588)4068874-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Arzneiform</subfield><subfield code="0">(DE-588)4068874-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Wirkstofffreisetzung</subfield><subfield code="0">(DE-588)4190018-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Kontrollierte Wirkstofffreisetzung</subfield><subfield code="0">(DE-588)4165181-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rosoff, Morton</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=001225892&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-001225892</subfield></datafield></record></collection> |
| genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
| genre_facet | Aufsatzsammlung |
| id | DE-604.BV001849953 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T15:36:34Z |
| institution | BVB |
| isbn | 0895733218 3527267972 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-001225892 |
| oclc_num | 18106215 |
| open_access_boolean | |
| owner | DE-12 DE-355 DE-BY-UBR DE-210 |
| owner_facet | DE-12 DE-355 DE-BY-UBR DE-210 |
| physical | XI, 315 S. Ill., graph. Darst. |
| publishDate | 1989 |
| publishDateSearch | 1989 |
| publishDateSort | 1989 |
| publisher | VCH |
| record_format | marc |
| spelling | Controlled release of drugs polymers and aggregate systems ed. by Morton Rosoff New York, NY u.a. VCH 1989 XI, 315 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Controlled release technology Delayed-Action Preparations Dosage Forms Drug carriers (Pharmacy) Drugs Controlled release Polymers therapeutic use Wirkstofffreisetzung (DE-588)4190018-2 gnd rswk-swf Kontrollierte Wirkstofffreisetzung (DE-588)4165181-9 gnd rswk-swf Arzneimittel (DE-588)4003115-9 gnd rswk-swf Arzneiform (DE-588)4068874-4 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content Arzneiform (DE-588)4068874-4 s Wirkstofffreisetzung (DE-588)4190018-2 s DE-604 Kontrollierte Wirkstofffreisetzung (DE-588)4165181-9 s Arzneimittel (DE-588)4003115-9 s Rosoff, Morton Sonstige oth GBV Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=001225892&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Controlled release of drugs polymers and aggregate systems Controlled release technology Delayed-Action Preparations Dosage Forms Drug carriers (Pharmacy) Drugs Controlled release Polymers therapeutic use Wirkstofffreisetzung (DE-588)4190018-2 gnd Kontrollierte Wirkstofffreisetzung (DE-588)4165181-9 gnd Arzneimittel (DE-588)4003115-9 gnd Arzneiform (DE-588)4068874-4 gnd |
| subject_GND | (DE-588)4190018-2 (DE-588)4165181-9 (DE-588)4003115-9 (DE-588)4068874-4 (DE-588)4143413-4 |
| title | Controlled release of drugs polymers and aggregate systems |
| title_auth | Controlled release of drugs polymers and aggregate systems |
| title_exact_search | Controlled release of drugs polymers and aggregate systems |
| title_full | Controlled release of drugs polymers and aggregate systems ed. by Morton Rosoff |
| title_fullStr | Controlled release of drugs polymers and aggregate systems ed. by Morton Rosoff |
| title_full_unstemmed | Controlled release of drugs polymers and aggregate systems ed. by Morton Rosoff |
| title_short | Controlled release of drugs |
| title_sort | controlled release of drugs polymers and aggregate systems |
| title_sub | polymers and aggregate systems |
| topic | Controlled release technology Delayed-Action Preparations Dosage Forms Drug carriers (Pharmacy) Drugs Controlled release Polymers therapeutic use Wirkstofffreisetzung (DE-588)4190018-2 gnd Kontrollierte Wirkstofffreisetzung (DE-588)4165181-9 gnd Arzneimittel (DE-588)4003115-9 gnd Arzneiform (DE-588)4068874-4 gnd |
| topic_facet | Controlled release technology Delayed-Action Preparations Dosage Forms Drug carriers (Pharmacy) Drugs Controlled release Polymers therapeutic use Wirkstofffreisetzung Kontrollierte Wirkstofffreisetzung Arzneimittel Arzneiform Aufsatzsammlung |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=001225892&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT rosoffmorton controlledreleaseofdrugspolymersandaggregatesystems |